RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The Learning Portal will be under maintenance Saturday, 8 August between 6 AM and 6 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Debt Levels Could Drive Pharma Companies Out

Debt Levels Could Drive Pharma Companies Out

Posted 23 February 2012 | By

Increasing debt at hospitals in Greece are threatening drug supplies and may force some companies out of business, according to a Greek pharmaceutical association.

PMLive Intelligence reports the Hellenic Association of Pharmaceutical Companies is warning that hospitals run by the national social security organization in Greece have already run up debts of €500 million. This news comes at a time when the country is seeking a bailout package from the EU to prevent defaults.

Proposed measures include a debt swap with pharmaceutical companies in an effort to settle overdue claims.

There are fears that new debt on top of past debt will drive pharmaceutical companies away from Greece and threaten the drug supply to hospitals.

Read more:
PMLive Intelligence Online: Greek hospital debt could drive pharma firms 'out of business'

Regulatory Focus newsletters

All the biggest regulatory news and happenings.